Literature DB >> 18635245

Phosphorylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and has an important regulative function.

Mona Johannessen1, Marit Renée Myhre, Marte Dragset, Conny Tümmler, Ugo Moens.   

Abstract

The human polyomavirus BK (BKV) genome encodes the capsid proteins VP1 to VP3 and the three regulatory proteins, large and small tumor-antigen and the agnoprotein. Agnoprotein is a phospho-protein, but phosphorylation sites, protein kinases that mediate phosphorylation, and the biological importance of phosphorylation for the life-cycle of BK virus remain unknown. Here, we show that protein kinase C phosphorylates BKV agnoprotein at serine-11. Replacing serine-11 by either non-phosphorylable alanine or phospho-mimicking aspartic acid reduced the ability of these mutants to propagate compared to wildtype virus. Moreover, both these mutants displayed altered expression of viral proteins, which resulted from changed transrepressive property and stability of the mutated agnoprotein. Our results indicate that BKV propagation is controlled by phosphorylation of the agnoprotein and may suggest that specific inhibition of protein kinases may be used as a therapeutic strategy to hamper BK virus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635245     DOI: 10.1016/j.virol.2008.06.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.

Authors:  A Sami Saribas; Pascale Coric; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2018-11-02       Impact factor: 6.384

2.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

3.  Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function.

Authors:  A Sami Saribas; Buenafe T Arachea; Martyn K White; Ronald E Viola; Mahmut Safak
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

4.  Nuclear Magnetic Resonance Structure of the Human Polyoma JC Virus Agnoprotein.

Authors:  Pascale Coric; A Sami Saribas; Magid Abou-Gharbia; Wayne Childers; Jon H Condra; Martyn K White; Mahmut Safak; Serge Bouaziz
Journal:  J Cell Biochem       Date:  2017-05-03       Impact factor: 4.429

5.  Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts.

Authors:  A Sami Saribas; Magid Abou-Gharbia; Wayne Childers; Ilker K Sariyer; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2013-06-06       Impact factor: 3.616

Review 6.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

7.  Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  J Cell Physiol       Date:  2017-08-28       Impact factor: 6.384

8.  JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2012-07-27       Impact factor: 3.616

9.  Generation and characterization of JCV permissive hybrid cell lines.

Authors:  Ilker K Sariyer; Mahmut Safak; Jennifer Gordon; Kamel Khalili
Journal:  J Virol Methods       Date:  2009-03-04       Impact factor: 2.014

Review 10.  Regulation of gene expression in primate polyomaviruses.

Authors:  Martyn K White; Mahmut Safak; Kamel Khalili
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.